JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kojima, H.
Right arrow Articles by Datta, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kojima, H.
Right arrow Articles by Datta, R.

J Biol Chem, Vol. 273, Issue 27, 16647-16650, July 3, 1998

COMMUNICATION
Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance

Hiromi KojimaDagger , Kazuya Endo, Hiroshi MoriyamaDagger , Yasuhiro TanakaDagger , Emad S. Alnemriparallel , Christopher A. Slapak**, Beverly Teicher**, Donald Kufe, and Rakesh Datta

From the  Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, the Dagger  Department of Otolaryngology, The Jikei University School of Medicine, Tokyo 105, Japan, the parallel  Department of Microbiology and Immunology, Kimmel Cancer Institute, Philadelphia, Pennsylvania 19107, and the ** Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285

Acquired multidrug resistance to anti-cancer agents has been associated with overexpression of the P-glycoprotein and other members of the ATP-binding cassette superfamily. The present studies demonstrate that SCC-25 cells selected for resistance to the alkylating agent cisplatin (CDDP) overexpress the anti-apoptotic Bcl-xL protein. In contrast to parental cells, the SCC-25/CDDP-resistant variant failed to exhibit activation of caspase-3, cleavage of protein kinase C delta , and other characteristics of apoptosis in response to CDDP. Similar results were obtained when SCC-25/CDDP cells were exposed to the structurally and functionally unrelated antimetabolite 1-beta -D-arabinofuranosyl-cytosine (ara-C). Other cells selected for resistance to doxorubicin or vincristine also exhibited overexpression of Bcl-xL and failed to respond to CDDP and ara-C with activation of caspase-3. The results further demonstrate that multidrug-resistant cells exhibit a block in the release of mitochondrial cytochrome c into the cytosol and that this effect is dependent on overexpression of Bcl-xL. The demonstration that lysates from the resistant cells respond to the addition of cytochrome c with activation of caspase-3 confirms that the block in apoptosis is because of inhibition of mitochondrial cytochrome c release. These findings demonstrate that cells respond to diverse classes of anti-cancer drugs with overexpression of Bcl-xL and that this response represents another mechanism of acquired multidrug resistance.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Cancer Res.Home page
O. Fantappie, M. Solazzo, N. Lasagna, F. Platini, L. Tessitore, and R. Mazzanti
P-Glycoprotein Mediates Celecoxib-Induced Apoptosis in Multiple Drug-Resistant Cell Lines
Cancer Res., May 15, 2007; 67(10): 4915 - 4923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Raina, S. Kharbanda, and D. Kufe
The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 Fibroblasts
J. Biol. Chem., May 14, 2004; 279(20): 20607 - 20612.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Holleman, M. L. d. Boer, K. M. Kazemier, G. E. Janka-Schaub, and R. Pieters
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia
Blood, December 15, 2003; 102(13): 4541 - 4546.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. S. RAIT, K. F. PIROLLO, D. ULICK, K. CULLEN, and E. H. CHANG
HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents
Ann. N.Y. Acad. Sci., December 1, 2003; 1002(1): 78 - 89.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. A. Vasilevskaya, T. V. Rakitina, and P. J. O'Dwyer
Geldanamycin and its 17-Allylamino-17-Demethoxy Analogue Antagonize the Action of Cisplatin in Human Colon Adenocarcinoma Cells: Differential Caspase Activation as a Basis for Interaction
Cancer Res., June 15, 2003; 63(12): 3241 - 3246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Nowak
Protein Kinase C-alpha and ERK1/2 Mediate Mitochondrial Dysfunction, Decreases in Active Na+ Transport, and Cisplatin-induced Apoptosis in Renal Cells
J. Biol. Chem., November 1, 2002; 277(45): 43377 - 43388.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. M. Gonzalez, M. A. Fuertes, C. Alonso, and J. M. Perez
Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?
Mol. Pharmacol., April 1, 2001; 59(4): 657 - 663.
[Full Text]


Home page
Cancer Res.Home page
X. Li, M. Marani, R. Mannucci, B. Kinsey, F. Andriani, I. Nicoletti, L. Denner, and M. Marcelli
Overexpression of BCL-XL Underlies the Molecular Basis for Resistance to Staurosporine-induced Apoptosis in PC-3 Cells
Cancer Res., February 1, 2001; 61(4): 1699 - 1706.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
X.-H. Yang, T. L. Sladek, X. Liu, B. R. Butler, C. J. Froelich, and A. D. Thor
Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin- and Etoposide-induced Apoptosis
Cancer Res., January 1, 2001; 61(1): 348 - 354.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
U. Zangemeister-Wittke, S. H. Leech, R. A. Olie, A. P. Simões-Wüst, O. Gautschi, G. H. Luedke, F. Natt, R. Häner, P. Martin, J. Hall, et al.
A Novel Bispecific Antisense Oligonucleotide Inhibiting Both bcl-2 and bcl-xL Expression Efficiently Induces Apoptosis in Tumor Cells
Clin. Cancer Res., June 1, 2000; 6(6): 2547 - 2555.
[Abstract] [Full Text]


Home page
Arch Otolaryngol Head Neck SurgHome page
H. Kojima, H. Miyazaki, Y. Tanaka, M. Shiwa, T. Koga, and H. Moriyama
Role of Bcl-xL Protein in Differentiation and Apoptosis of Human Middle Ear Cholesteatoma Epithelium
Arch Otolaryngol Head Neck Surg, July 1, 1999; 125(7): 738 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Wartenberg, F. C. Ling, M. Schallenberg, A. T. Baumer, K. Petrat, J. Hescheler, and H. Sauer
Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen Species
J. Biol. Chem., May 11, 2001; 276(20): 17420 - 17428.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Datta, E. Oki, K. Endo, V. Biedermann, J. Ren, and D. Kufe
XIAP Regulates DNA Damage-induced Apoptosis Downstream of Caspase-9 Cleavage
J. Biol. Chem., October 6, 2000; 275(41): 31733 - 31738.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.